Grifols reported EUR6.08B in Equity Capital and Reserves for its fiscal quarter ending in September of 2025.





Equity Capital And Reserves Change Date
Alaunos Therapeutics USD 2.8M 858K Sep/2025
aTyr Pharma USD 80.24M 5.58M Sep/2025
GlaxoSmithKline GBP 16.38B 229M Dec/2025
Grifols EUR 6.08B 34.72M Sep/2025